Neutralizing antiviral antibody responses

[1]  M. Daëron,et al.  Fc receptor biology. , 2003, Annual review of immunology.

[2]  P. Klenerman,et al.  Impairment of Cd4+ T Cell Responses during Chronic Virus Infection Prevents Neutralizing Antibody Responses against Virus Escape Mutants , 2001, The Journal of experimental medicine.

[3]  R M Zinkernagel,et al.  Natural antibodies and complement link innate and acquired immunity. , 2000, Immunology today.

[4]  R. Zinkernagel,et al.  Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Andreas Holz,et al.  Immunosuppression and Resultant Viral Persistence by Specific Viral Targeting of Dendritic Cells , 2000, The Journal of experimental medicine.

[6]  M. Cho,et al.  Identification of gp120 Regions Targeted by a Highly Potent Neutralizing Antiserum Elicited in a Chimpanzee Inoculated with a Primary Human Immunodeficiency Virus Type 1 Isolate , 2000, Journal of Virology.

[7]  K. Rajewsky,et al.  Memory B-cell persistence is independent of persisting immunizing antigen , 2000, Nature.

[8]  Rolf M. Zinkernagel,et al.  What is missing in immunology to understand immunity? , 2000, Nature Immunology.

[9]  R. Zinkernagel,et al.  Correlation of anti-viral B cell responses and splenic morphology with expression of B cell-specific molecules. , 2000, International immunology.

[10]  R. Zinkernagel,et al.  Virus neutralization by germ-line vs. hypermutated antibodies. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[11]  N. Baumgarth,et al.  A two‐phase model of B‐cell activation , 2000, Immunological reviews.

[12]  M. Reth,et al.  An unsolved problem of the clonal selection theory and the model of an oligomeric B‐cell antigen receptor , 2000, Immunological reviews.

[13]  Jianzhu Chen,et al.  B-1 and B-2 Cell–Derived Immunoglobulin M Antibodies Are Nonredundant Components of the Protective Response to Influenza Virus Infection , 2000, The Journal of experimental medicine.

[14]  R. Zinkernagel,et al.  A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. , 2000, Science.

[15]  R. Zinkernagel,et al.  Correlation of T Cell Independence of Antibody Responses with Antigen Dose Reaching Secondary Lymphoid Organs: Implications for Splenectomized Patients and Vaccine Design1 , 2000, The Journal of Immunology.

[16]  J. D. Capra,et al.  Receptor Revision of Immunoglobulin Heavy Chain Variable Region Genes in Normal Human B Lymphocytes , 2000, The Journal of experimental medicine.

[17]  D. Burton,et al.  Antibody and virus: binding and neutralization. , 2000, Virology.

[18]  H J Alter,et al.  The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. , 2000, Science.

[19]  V. Kouskoff,et al.  T cell-independent rescue of B lymphocytes from peripheral immune tolerance. , 2000, Science.

[20]  G. Ada.  HIV and pandemic influenza virus: two great infectious disease challenges. , 2000, Virology.

[21]  P. Klenerman,et al.  Viral persistence in vivo through selection of neutralizing antibody-escape variants. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Wilson,et al.  Epitopes involved in antibody-mediated protection from Ebola virus. , 2000, Science.

[23]  J. Mascola,et al.  Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies , 2000, Nature Medicine.

[24]  Tahir A. Rizvi,et al.  Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian–human immunodeficiency virus infection , 2000, Nature Medicine.

[25]  Z. Chen,et al.  Neuropathogenicity and sensitivity to antibody neutralization of lactate dehydrogenase-elevating virus are determined by polylactosaminoglycan chains on the primary envelope glycoprotein. , 2000, Virology.

[26]  Ying-hua Chen,et al.  Epitope-vaccine induces high levels of ELDKWA-epitope-specific neutralizing antibody , 2000, Immunological investigations.

[27]  R. Zinkernagel,et al.  Control of early viral and bacterial distribution and disease by natural antibodies. , 1999, Science.

[28]  F. Cutts,et al.  Edmonston-Zagreb Measles Vaccine: A Good Vaccine With an Image Problem , 1999, Pediatrics.

[29]  N. Enomoto,et al.  Prevalence and significance of naturally occurring mutations in the surface and polymerase genes of hepatitis B virus. , 1999, The Journal of infectious diseases.

[30]  R. Zinkernagel,et al.  Protective T Cell–Independent Antiviral Antibody Responses Are Dependent on Complement , 1999, The Journal of experimental medicine.

[31]  P. Klenerman,et al.  Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Ruprecht.  Live attenuated AIDS viruses as vaccines: promise or peril? , 1999, Immunological reviews.

[33]  J. Mckinney,et al.  The death and resurrection of tuberculosis , 1999, Nature Medicine.

[34]  R. Zinkernagel,et al.  Secondary Rearrangements and Hypermutation Generate Sufficient B Cell Diversity to Mount Protective Antiviral Immunoglobulin Responses , 1999, The Journal of experimental medicine.

[35]  B. Ludewig,et al.  Role of dendritic cells in the induction and maintenance of autoimmune diseases , 1999, Immunological reviews.

[36]  M. Bachmann,et al.  Influenza virus: a novel method to assess viral and neutralizing antibody titers in vitro. , 1999, Journal of immunological methods.

[37]  A. Llera,et al.  Lack of significant differences in association rates and affinities of antibodies from short-term and long-term responses to hen egg lysozyme. , 1999, Journal of immunology.

[38]  D. B. Anderson,et al.  Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression , 1999, Nature Medicine.

[39]  D. Montefiori,et al.  Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors. , 1999, The Journal of infectious diseases.

[40]  J. Mascola,et al.  Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies , 1999, Journal of Virology.

[41]  R. Zinkernagel,et al.  In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody. , 1999, Journal of immunology.

[42]  P. Klenerman,et al.  General and specific immunosuppression caused by antiviral T‐cell responses , 1999, Immunological reviews.

[43]  I. Frazer,et al.  Potential strategies utilised by papillomavirus to evade host immunity , 1999, Immunological reviews.

[44]  H. Katinger,et al.  Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo. , 1999, Immunity.

[45]  D. Lowy,et al.  Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[46]  N. Haigwood,et al.  Neutralizing antibody directed against the HIV–1 envelope glycoprotein can completely block HIV–1/SIV chimeric virus infections of macaque monkeys , 1999, Nature Medicine.

[47]  S. Rubino,et al.  Molecular typing of non-typhoid Salmonella strains isolated from HIV-infected patients with recurrent salmonellosis. , 1999, AIDS.

[48]  S. Schrag,et al.  Spontaneous Mutation Rate of Measles Virus: Direct Estimation Based on Mutations Conferring Monoclonal Antibody Resistance , 1999, Journal of Virology.

[49]  Jianzhu Chen,et al.  A Critical Role of Natural Immunoglobulin M in Immediate Defense Against Systemic Bacterial Infection , 1998, The Journal of experimental medicine.

[50]  P. Lambert,et al.  Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime‐boost strategies in mice , 1998, European journal of immunology.

[51]  H Hengartner,et al.  Mathematical model of a virus-neutralizing immunglobulin response. , 1998, Journal of theoretical biology.

[52]  Andreas Radbruch,et al.  Survival of long-lived plasma cells is independent of antigen. , 1998, International immunology.

[53]  R. Zinkernagel,et al.  Dendritic Cells Induce Autoimmune Diabetes and Maintain Disease via De Novo Formation of Local Lymphoid Tissue , 1998, The Journal of experimental medicine.

[54]  R. Zinkernagel,et al.  Comparison of activation versus induction of unresponsiveness of virus-specific CD4+ and CD8+ T cells upon acute versus persistent viral infection. , 1998, Immunity.

[55]  J. Goudsmit,et al.  Neutralizing antibodies are positively associated with CD4+ T‐cell counts and T‐cell function in long‐term AIDS‐free infection , 1998, AIDS.

[56]  M. Neuberger,et al.  Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[57]  J. Banchereau,et al.  Antigen Receptor Engagement Turns off the V(D)J Recombination Machinery in Human Tonsil B Cells , 1998, The Journal of experimental medicine.

[58]  W. P. Glezen,et al.  Maternal immunization against viral disease. , 1998, Vaccine.

[59]  M. Billeter,et al.  T-cell independent IgM and enduring protective IgG antibodies induced by chimeric measles viruses , 1998, Nature Medicine.

[60]  R. Ahmed,et al.  Immunity to infection. , 1998, Current opinion in immunology.

[61]  V. Kouskoff,et al.  V(D)J recombinase induction in splenic B lymphocytes is inhibited by antigen-receptor signalling , 1998, Nature.

[62]  T. Behrens,et al.  Self-reactive B lymphocytes overexpressing Bcl-xL escape negative selection and are tolerized by clonal anergy and receptor editing. , 1998, Immunity.

[63]  R. Zinkernagel,et al.  Antiviral Protection and Germinal Center Formation, But Impaired B Cell Memory in the Absence of CD19 , 1998, The Journal of experimental medicine.

[64]  R. Ahmed,et al.  Long-lived plasma cells: a mechanism for maintaining persistent antibody production. , 1998, Current opinion in immunology.

[65]  R. Means,et al.  A role for carbohydrates in immune evasion in AIDS , 1998, Nature Medicine.

[66]  Jianzhu Chen,et al.  Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. , 1998, Journal of immunology.

[67]  Ding‐Shinn Chen,et al.  Hepatitis B Virus Infection , 2007 .

[68]  G. Kelsoe,et al.  Dependence of germinal center B cells on expression of CD21/CD35 for survival. , 1998, Science.

[69]  M. Diaz,et al.  Evolution of somatic hypermutation and gene conversion in adaptive immunity , 1998, Immunological reviews.

[70]  J. Hoxie,et al.  Evidence that Antibody-Mediated Neutralization of Human Immunodeficiency Virus Type 1 by Sera from Infected Individuals Is Independent of Coreceptor Usage , 1998, Journal of Virology.

[71]  S. Zolla-Pazner,et al.  Coreceptor Utilization by Human Immunodeficiency Virus Type 1 Is Not a Primary Determinant of Neutralization Sensitivity , 1998, Journal of Virology.

[72]  A. Trkola,et al.  Neutralization Sensitivity of Human Immunodeficiency Virus Type 1 Primary Isolates to Antibodies and CD4-Based Reagents Is Independent of Coreceptor Usage , 1998, Journal of Virology.

[73]  R. Holmdahl,et al.  Arthritis-related B Cell Epitopes in Collagen II Are Conformation-dependent and Sterically Privileged in Accessible Sites of Cartilage Collagen Fibrils* , 1998, The Journal of Biological Chemistry.

[74]  H. Thomas,et al.  Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients , 1998, Hepatology.

[75]  T. Berg,et al.  Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high‐dose hepatitis B immune globulin after liver transplantation , 1998, Hepatology.

[76]  R. Zinkernagel,et al.  Virus‐specific major MHC class II‐restricted TCR‐transgenic mice: effects on humoral and cellular immune responses after viral infection , 1998, European journal of immunology.

[77]  K. Rajewsky,et al.  Receptor editing in a transgenic mouse model: site, efficiency, and role in B cell tolerance and antibody diversification. , 1997, Immunity.

[78]  F. Chagnon,et al.  A recombinant single chain antibody neutralizes coronavirus infectivity but only slightly delays lethal infection of mice , 1997, European journal of immunology.

[79]  Heikyung Suh,et al.  V(D)J recombination in mature B cells: a mechanism for altering antibody responses. , 1997, Science.

[80]  G. Kelsoe,et al.  V(D)J recombinase activity in a subset of germinal center B lymphocytes. , 1997, Science.

[81]  R. Zinkernagel,et al.  Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection , 1997, European journal of immunology.

[82]  D. Montefiori,et al.  Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection. , 1997, The Journal of infectious diseases.

[83]  P. Lachmann,et al.  Complement and immunity to viruses , 1997, Immunological reviews.

[84]  H. Hsu,et al.  Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis , 1997, Hepatology.

[85]  J. Atkinson,et al.  Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction. , 1997, The Journal of general virology.

[86]  L. Matter,et al.  [Mumps epidemic in vaccinated children in West Switzerland]. , 1997, Schweizerische medizinische Wochenschrift.

[87]  M Aguet,et al.  The role of antibody concentration and avidity in antiviral protection. , 1997, Science.

[88]  R M Zinkernagel,et al.  A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[89]  P. Stewart,et al.  Recent structural solutions for antibody neutralization of viruses. , 1997, Trends in microbiology.

[90]  R. Zinkernagel,et al.  Correlation of tolerogenicity of a viral antigen with its immunogenicity. , 1997, Journal of immunology.

[91]  A. Coutinho,et al.  The repertoire of serum IgM in normal mice is largely independent of external antigenic contact , 1997, European journal of immunology.

[92]  K. Mozdzanowska,et al.  A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro , 1997, Journal of virology.

[93]  R. Zinkernagel,et al.  Role of Repetitive Antigen Patterns for Induction of Antibodies Against Antibodies , 1997, The Journal of experimental medicine.

[94]  R M Zinkernagel,et al.  Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology. , 1997, Immunity.

[95]  H. Fleury,et al.  Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals , 1997, Journal of virology.

[96]  M. Aye,et al.  Risk factors in dengue shock syndrome. , 1997, The American journal of tropical medicine and hygiene.

[97]  S. Galli,et al.  Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis. , 1997, The Journal of clinical investigation.

[98]  R. Zinkernagel,et al.  Virus-induced Transient Bone Marrow Aplasia: Major Role of Interferon-α/β during Acute Infection with the Noncytopathic Lymphocytic Choriomeningitis Virus , 1997, The Journal of experimental medicine.

[99]  R. Zinkernagel,et al.  Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"? , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[100]  M. Buchmeier,et al.  Antibody prevents the establishment of persistent arenavirus infection in synergy with endogenous T cells , 1997, Journal of virology.

[101]  M. Shapiro,et al.  Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[102]  R. Zinkernagel,et al.  The role of somatic mutation in the generation of the protective humoral immune response against vesicular stomatitis virus. , 1996, Immunity.

[103]  R. Zinkernagel,et al.  The influence of virus structure on antibody responses and virus serotype formation. , 1996, Immunology today.

[104]  R. Zinkernagel,et al.  Monovalent single‐chain Fv fragments and bivalent miniantibodies bound to vesicular stomatitis virus protect against lethal infection , 1996, European journal of immunology.

[105]  L. Brent.  A history of transplantation immunology , 1996 .

[106]  William C. Olson,et al.  CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5 , 1996, Nature.

[107]  M. Jackson,et al.  B cells are exquisitely sensitive to central tolerance and receptor editing induced by ultralow affinity, membrane-bound antigen , 1996, The Journal of experimental medicine.

[108]  J. Christensen,et al.  Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice. , 1996, Journal of immunology.

[109]  F. Chisari,et al.  The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T–lymphocyte response , 1996, Nature Medicine.

[110]  Timothy S. Baker,et al.  Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon , 1996, Nature.

[111]  H. Pircher,et al.  On the role of antigen in maintaining cytotoxic T-cell memory. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[112]  M. Manns,et al.  Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis , 1996, Hepatology.

[113]  Klaus Rajewsky,et al.  Immunity to viruses in B cell‐deficient mice: Influence of antibodies on virus persistence and on T cell memory , 1996, European journal of immunology.

[114]  R. Zinkernagel,et al.  Specific cytotoxic T cells eliminate cells producing neutralizing antibodies , 1996, Nature.

[115]  M. Wabl,et al.  A Quasi-Monoclonal Mouse , 1996, Science.

[116]  Q. Sattentau,et al.  Antibody neutralization of HIV-1. , 1996, Immunology today.

[117]  R. Zinkernagel,et al.  CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions , 1996, The Journal of experimental medicine.

[118]  R. Karr,et al.  Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[119]  David Gray,et al.  Immunological Memory and Protective Immunity: Understanding Their Relation , 1996, Science.

[120]  R. Locksley,et al.  The Instructive Role of Innate Immunity in the Acquired Immune Response , 1996, Science.

[121]  R. Zinkernagel,et al.  Immunological Memory , 2006 .

[122]  N. Van Rooijen,et al.  Humoral Immune Responses Against Particulate Bacterial Antigens are Dependent on Marginal Metallophilic Macrophages in the Spleen , 1996, Scandinavian journal of immunology.

[123]  R. Zinkernagel,et al.  T-independent activation of B cells by vesicular stomatitis virus: no evidence for the need of a second signal. , 1996, Cellular immunology.

[124]  J. Ahearn,et al.  Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. , 1996, Immunity.

[125]  Christopher C. Goodnow,et al.  C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired Immunity , 1996, Science.

[126]  E. L. Prak,et al.  Immunoglobulin heavy chain gene replacement: a mechanism of receptor editing. , 1995, Immunity.

[127]  H. Hotta,et al.  Detection of measles virus nucleoprotein mRNA in autopsied brain tissues. , 1995, The Journal of general virology.

[128]  R. Zinkernagel,et al.  T helper cell‐independent neutralizing B cell response against vesicular stomatitis virus: Role of antigen patterns in B cell induction? , 1995, European journal of immunology.

[129]  L. Mimms,et al.  Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA , 1995, The Lancet.

[130]  M. Battegay,et al.  Fibroblasts as efficient antigen-presenting cells in lymphoid organs. , 1995, Science.

[131]  P. Talbot,et al.  Protection from lethal coronavirus infection by immunoglobulin fragments. , 1995, Journal of immunology.

[132]  R. Zinkernagel,et al.  Antiviral protection by vesicular stomatitis virus-specific antibodies in alpha/beta interferon receptor-deficient mice , 1995, Journal of virology.

[133]  R M Zinkernagel,et al.  Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[134]  P. Borrow,et al.  Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression , 1995, Journal of virology.

[135]  N. Dimmock,et al.  Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift. , 1994, The Journal of general virology.

[136]  R. Ahmed,et al.  CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection , 1994, Journal of virology.

[137]  R. Zinkernagel,et al.  Free recirculation of memory B cells versus antigen-dependent differentiation to antibody-forming cells. , 1994, Journal of immunology.

[138]  R. Zinkernagel,et al.  Regulation of IgG antibody titers by the amount persisting of immune‐complexed antigen , 1994, European journal of immunology.

[139]  D. Morens,et al.  Antibody-dependent enhancement of infection and the pathogenesis of viral disease. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[140]  I. Szymanski,et al.  Electron microscopic and immunochemical studies in a patient with hepatitis C virus infection and mixed cryoglobulinemia type II. , 1994, American journal of clinical pathology.

[141]  J. Ravetch.  Fc receptors: Rubor redux , 1994, Cell.

[142]  J. Moore,et al.  Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1 , 1994, Journal of virology.

[143]  R. Zinkernagel,et al.  Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice , 1994, Journal of virology.

[144]  R. Zinkernagel,et al.  Vesicular stomatitis virus Indiana glycoprotein as a T-cell-dependent and -independent antigen , 1994, Journal of virology.

[145]  Hans Hengartner,et al.  Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice , 1994, Nature.

[146]  R M Zinkernagel,et al.  How many specific B cells are needed to protect against a virus? , 1994, Journal of immunology.

[147]  M. Billeter,et al.  Generation and Properties of Measles Virus Mutations Typically Associated with Subacute Sclerosing Panencephalitis a , 1994, Annals of the New York Academy of Sciences.

[148]  R. Purcell,et al.  Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses , 1994, Journal of virology.

[149]  K. Mozdzanowska,et al.  Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. , 1994, Journal of immunology.

[150]  R. Zinkernagel,et al.  Enhancement of disease by neutralizing antiviral antibodies in the absence of primed antiviral cytotoxic T cells , 1993, European journal of immunology.

[151]  S. Halstead,et al.  Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials. , 1993, AIDS research and human retroviruses.

[152]  R. Zinkernagel,et al.  The influence of antigen organization on B cell responsiveness. , 1993, Science.

[153]  R M Zinkernagel,et al.  Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells. , 1993, Journal of immunology.

[154]  E. Domingo,et al.  Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection , 1993, Journal of virology.

[155]  Miguel Ángel Martínez,et al.  New observations on antigenic diversification of RNA viruses. Antigenic variation is not dependent on immune selection. , 1993, The Journal of general virology.

[156]  P. Borrow,et al.  Virus-induced immunosuppression. 1. Age at infection relates to a selective or generalized defect. , 1993, Virology.

[157]  R. Desrosiers,et al.  Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys , 1993, Journal of virology.

[158]  R. Ruigrok,et al.  Mechanisms of rabies virus neutralization. , 1993, Virology.

[159]  M. Cohn,et al.  Two signal models of lymphocyte activation? , 1993, Immunology today.

[160]  D. Nemazee,et al.  Receptor editing in self-reactive bone marrow B cells , 1993, The Journal of experimental medicine.

[161]  J Erikson,et al.  B lymphocytes may escape tolerance by revising their antigen receptors , 1993, The Journal of experimental medicine.

[162]  S. Camper,et al.  Receptor editing: an approach by autoreactive B cells to escape tolerance , 1993, The Journal of experimental medicine.

[163]  M. Cooke,et al.  Elimination of self-reactive B lymphocytes proceeds in two stages: Arrested development and cell death , 1993, Cell.

[164]  L. Herzenberg,et al.  B-cell lineages exist in the mouse. , 1993, Immunology today.

[165]  M. Buchmeier,et al.  Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection , 1992, Journal of virology.

[166]  R. Zinkernagel,et al.  Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation , 1992, European journal of immunology.

[167]  O. Mäkelä,et al.  Maternal antibodies partly inhibit an active antibody response to routine tetanus toxoid immunization in infants. , 1992, The Journal of infectious diseases.

[168]  Giorgio,et al.  Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[169]  R. Ahmed,et al.  Immunological memory against viruses. , 1992, Seminars in immunology.

[170]  J. Hansen,et al.  Autologous HIV‐1 Neutralizing Antibodies: Emergence of Neutralization‐Resistant Escape Virus and Subsequent Development of Escape Virus Neutralizing Antibodies , 1992, Journal of acquired immune deficiency syndromes.

[171]  H. Chapel,et al.  Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age , 1992, The Lancet.

[172]  L. Bradley,et al.  Helper T cell memory: more questions than answers. , 1992, Seminars in immunology.

[173]  Behring Von Stabsarzt,et al.  Ueber das zustandekommen der diphtherie-immunität und der tetanus-immunität bei thieren☆ , 1991 .

[174]  T. Crawford,et al.  Antibody-mediated clearance of alphavirus infection from neurons. , 1991, Science.

[175]  O. Leroy,et al.  Child mortality after high-titre measles vaccines: prospective study in Senegal , 1991, The Lancet.

[176]  E. Palmer,et al.  Mls--a retrovirus exploits the immune system. , 1991, Immunology today.

[177]  R. Zinkernagel,et al.  Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[178]  N. Cooper.  Complement evasion strategies of microorganisms. , 1991, Immunology today.

[179]  G. Morahan,et al.  Clonal Deletion of Autospecific B Lymphocytes , 1991, Immunological reviews.

[180]  H. Pircher,et al.  T and B cell Tolerance and Responses to Viral Antigens in Transgenic Mice: Implications for the Pathogenesis of Autoimmune versus Immunopathological Disease , 1991, Immunological reviews.

[181]  C. Goodnow,et al.  Self Tolerance in the B‐Cell Repertoire , 1991, Immunological reviews.

[182]  Klaus Rajewsky,et al.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene , 1991, Nature.

[183]  R. Zinkernagel,et al.  Vaccination for disease. , 1991, Science.

[184]  V. Racaniello,et al.  Poliovirus mutants resistant to neutralization with soluble cell receptors , 1990, Science.

[185]  R. Zinkernagel,et al.  Analysis of the kinetics of antiviral memory T help in vivo: characterization of short‐lived cross‐reactive T help , 1990, European journal of immunology.

[186]  L. Staudt,et al.  The BALB/c secondary response to the Sb site of influenza virus hemagglutinin. Nonrandom silent mutation and unequal numbers of VH and Vk mutations. , 1990, Journal of immunology.

[187]  G. F. Burton,et al.  Follicular Dendritic Cells as Accessory Cells , 1990, Immunological reviews.

[188]  M. Wainberg,et al.  Neutralization of multiple HIV-1 isolates from a single subject by autologous sequential sera. , 1990, The Journal of infectious diseases.

[189]  A. Zuckerman,et al.  Vaccine-induced escape mutant of hepatitis B virus , 1990, The Lancet.

[190]  M. Cohn,et al.  The Protection: The Unit of Humoral Immunity Selected by Evolution , 1990, Immunological Reviews.

[191]  P. Casali,et al.  Biological characterization of human monoclonal antibodies to rabies virus , 1990, Journal of virology.

[192]  G. Air,et al.  Epitopes on protein antigens: Misconceptions and realities , 1990, Cell.

[193]  R. Zinkernagel,et al.  Virus-induced autoantibody response to a transgenic viral antigen , 1990, Nature.

[194]  L. Staudt,et al.  V region gene usage and somatic mutation in the primary and secondary responses to influenza virus hemagglutinin. , 1990, Journal of immunology.

[195]  J. Allison,et al.  Origin of Thy-1+ dendritic epidermal cells of adult mice from fetal thymic precursors , 1990, Nature.

[196]  J. Albert,et al.  Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. , 1990, AIDS.

[197]  Jeffrey Crosbie,et al.  Induction of self-tolerance in mature peripheral B lymphocytes , 1989, Nature.

[198]  P. Casali,et al.  CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. , 1989, Immunology today.

[199]  R. Benner,et al.  B cell repertoire in adult antigen‐free and conventional neonatal balb/c mice , 1989, European journal of immunology.

[200]  D. Nemazee,et al.  Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[201]  N. Bos,et al.  B cell repertoire in adult antigen‐free and conventional neonatal balb/c mice , 1989, European journal of immunology.

[202]  M. Lopes-Virella,et al.  Diabetes, autoimmunity, and arteriosclerosis. , 1989, Clinical immunology and immunopathology.

[203]  H. Dintzis,et al.  The immunogenicity of soluble haptenated polymers is determined by molecular mass and hapten valence. , 1989, Journal of immunology.

[204]  Miguel Ángel Martínez,et al.  Implications of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[205]  A. Coutinho,et al.  Beyond Clonal Selection and Network , 1989, Immunological reviews.

[206]  M. Buchmeier,et al.  Neutralizing epitopes of lymphocytic choriomeningitis virus are conformational and require both glycosylation and disulfide bonds for expression. , 1989, Virology.

[207]  T. Matthews,et al.  MATERNAL PYREXIA AND THE FETUS , 1989, The Lancet.

[208]  R. Schwartz.  Acquisition of immunologic self-tolerance , 1989, Cell.

[209]  J. Levy,et al.  The FC and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. , 1989, Disease markers.

[210]  Z. Fishelson,et al.  Targeting of complement to tumor cells by heteroconjugates composed of antibodies and of the complement component C3b. , 1989, Journal of immunology.

[211]  M. Reth.  Antigen receptor tail clue , 1989, Nature.

[212]  P. Collier,et al.  LOCHGOILHEAD FEVER: OUTBREAK OF NON-PNEUMONIC LEGIONELLOSIS DUE TO LEGIONELLA MICDADEI , 1989, The Lancet.

[213]  D. Nemazee,et al.  Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes , 1989, Nature.

[214]  F. Ennis,et al.  Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. , 1988, Science.

[215]  P. Jahrling,et al.  Immune serum increases arenavirus replication in monocytes. , 1988, The Journal of general virology.

[216]  R. M. Iorio.  Mechanisms of neutralization of animal viruses: monoclonal antibodies provide a new perspective. , 1988, Microbial pathogenesis.

[217]  A. Alberti,et al.  ANTIBODY RESPONSE TO PRE-S2 AND HEPATITIS B VIRUS INDUCED LIVER DAMAGE , 1988, The Lancet.

[218]  C. Vermylen,et al.  BONE MARROW TRANSPLANTATION IN FIVE CHILDREN WITH SICKLE CELL ANAEMIA , 1988, The Lancet.

[219]  E. Domingo,et al.  Rapid selection of genetic and antigenic variants of foot-and-mouth disease virus during persistence in cattle , 1988, Journal of virology.

[220]  R. Zinkernagel,et al.  Virus-triggered immune suppression in mice caused by virus-specific cytotoxic T cells , 1988, The Journal of experimental medicine.

[221]  D. Montefiori,et al.  ANTIBODY-DEPENDENT ENHANCEMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION , 1988, The Lancet.

[222]  Y. Li,et al.  Point mutations in glycoprotein gene of vesicular stomatitis virus (New Jersey serotype) selected by resistance to neutralization by epitope-specific monoclonal antibodies. , 1988, Virology.

[223]  F. Brown.  Use of peptides for immunization against foot-and-mouth disease. , 1988, Vaccine.

[224]  S. Halstead,et al.  Pathogenesis of dengue: challenges to molecular biology. , 1988, Science.

[225]  H. Lutz,et al.  Naturally occurring anti-band-3 antibodies and complement together mediate phagocytosis of oxidatively stressed human erythrocytes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[226]  R. Webster,et al.  Influenza virus a pathogenicity: The pivotal role of hemagglutinin , 1987, Cell.

[227]  D. Moskophidis,et al.  Antiviral antibody-producing cells in parenchymatous organs during persistent virus infection , 1987, The Journal of experimental medicine.

[228]  I. Cohen.  Regulation of Autoimmune Disease Physiological and Therapeutic , 1986, Immunological reviews.

[229]  K. Cantell,et al.  OUTBREAK OF PARALYTIC POLIOMYELITIS IN FINLAND: WIDESPREAD CIRCULATION OF ANTIGENICALLY ALTERED POLIOVIRUS TYPE 3 IN A VACCINATED POPULATION , 1986, The Lancet.

[230]  R. Zinkernagel,et al.  Antibody mediated suppression of secondary IgM response in nude mice against vesicular stomatitis virus. , 1986, Journal of immunology.

[231]  R M Zinkernagel,et al.  Primary antibody responses to a well-defined and unique hapten are not enhanced by preimmunization with carrier: analysis in a viral model. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[232]  J. Skehel,et al.  Comparative analyses of the specificities of anti-influenza hemagglutinin antibodies in human sera , 1986, Journal of virology.

[233]  S. Kuge,et al.  Antigenic variation and resistance to neutralization in poliovirus type 1. , 1985, Science.

[234]  P. Biberfeld,et al.  Immunohistopathology of lymph nodes in HTLV-III infected homosexuals with persistent adenopathy or AIDS. , 1985, Cancer research.

[235]  G. Klein,et al.  gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[236]  A. Sabin.  Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world. , 1985, The Journal of infectious diseases.

[237]  M. Frank,et al.  C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I , 1984, The Journal of experimental medicine.

[238]  G. Nemerow,et al.  The role of antibody and complement in the control of viral infections. , 1984, The Journal of investigative dermatology.

[239]  L. Lefrançois.  Protection against lethal viral infection by neutralizing and nonneutralizing monoclonal antibodies: distinct mechanisms of action in vivo , 1984, Journal of virology.

[240]  N. Dimmock.  Mechanisms of neutralization of animal viruses. , 1984, The Journal of general virology.

[241]  N. K. Jerne,et al.  Idiotypic Networks and Other Preconceived Ideas , 1984, Immunological reviews.

[242]  L. Staudt,et al.  Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[243]  I. Wilson,et al.  A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[244]  M. Mondelli,et al.  Mechanisms of Liver Cell Injury in Acute and Chronic Hepatitis B , 1984, Seminars in liver disease.

[245]  E. Wimmer,et al.  Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization , 1983, Journal of virology.

[246]  N. Cox,et al.  Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites , 1983, Journal of virology.

[247]  A. Sabin,et al.  Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines. , 1983, JAMA.

[248]  S. Ofosu-amaah.  The control of measles in tropical Africa: a review of past and present efforts. , 1983, Reviews of infectious diseases.

[249]  B. Ashworth,et al.  Immunodeficiency measles encephalitis. , 1983, Journal of clinical & laboratory immunology.

[250]  L. Staudt,et al.  Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. I. Significant variation in repertoire expression between individual mice , 1983, The Journal of experimental medicine.

[251]  L. Lefrançois,et al.  Antigenic determinants of vesicular stomatitis virus: analysis with antigenic variants. , 1983, Journal of immunology.

[252]  D. Jackson,et al.  Enumeration of antigenic sites of influenza virus hemagglutinin , 1982, Infection and immunity.

[253]  Richard A. Houghten,et al.  Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence , 1982, Nature.

[254]  Katherine Spindler,et al.  Rapid evolution of RNA genomes. , 1982, Science.

[255]  W G Laver,et al.  Molecular mechanisms of variation in influenza viruses , 1982, Nature.

[256]  F. Scott,et al.  Antibody-mediated enhancement of disease in feline infectious peritonitis: Comparisons with dengue hemorrhagic fever☆ , 1981, Comparative Immunology, Microbiology and Infectious Diseases.

[257]  S. Groth.  The Joint Evolution of Antigens and Antibodies , 1981 .

[258]  A. Sabin.  Paralytic poliomyelitis: Old dogmas and new perspectives. , 1981, Reviews of infectious diseases.

[259]  N. Cooper,et al.  Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum. , 1981, Journal of immunology.

[260]  I. Wilson,et al.  Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation , 1981, Nature.

[261]  M. Buchmeier,et al.  Virus-induced immune complex disease: specific anti-viral antibody and C1q binding material in the circulation during persistent lymphocytic choriomeningitis virus infection. , 1980, Journal of immunology.

[262]  N. Nathanson,et al.  The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance. , 1979, American journal of epidemiology.

[263]  P. Doherty,et al.  Inhibition of influenza-immune T cell effector function by virus-specific hybridoma antibody. , 1979, Journal of immunology.

[264]  I. Mackay,et al.  AUTOIMMUNE DISEASE AND THE THEORY OF CLONAL ABORTION Is It Still Relevant? , 1979, The Lancet.

[265]  R. Webster,et al.  Antigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule , 1979, Nature.

[266]  B. Mandel.  Neutralization of Animal Viruses , 1978, Advances in Virus Research.

[267]  N. Cooper,et al.  Antibody-independent neutralization of vesicular stomatitis virus by human complement. II. Formation of VSV-lipoprotein complexes in human serum and complement-dependent viral lysis. , 1978, Journal of immunology.

[268]  N. Cooper,et al.  Antibody-independent neutralization of vesicular stomatitis virus by human complement. I. Complement requirements. , 1978, Journal of immunology.

[269]  T. Lint,et al.  Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein‐Barr virus transformation of the cells , 1978, European journal of immunology.

[270]  S. Silberman,et al.  Mechanisms of hemopoietic and immunological dysfunction induced by lymphocytic choriomeningitis virus , 1978, Infection and immunity.

[271]  F. Rosen,et al.  Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia. , 1977, The New England journal of medicine.

[272]  J. Skehel,et al.  Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses , 1977, Nature.

[273]  B. Vogelstein,et al.  Molecular determinants of immunogenicity: the immunon model of immune response. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[274]  G. Cole,et al.  Lymphocytic choriomeningitis virus-induced immunosuppression: a virus-induced macrophage defect. , 1976, Journal of immunology.

[275]  S. Tonegawa,et al.  Somatic generation of antibody diversity. , 1976, Nature.

[276]  B. Mandel.  Neutralization of poliovirus: a hypothesis to explain the mechanism and the one-hit character of the neutralization reaction. , 1976, Virology.

[277]  F. Jensen,et al.  Human serum lyses RNA tumour viruses , 1975, Nature.

[278]  G. Möller,et al.  One Non‐Specific Signal Triggers B Lymphocytes , 1975, Transplantation reviews.

[279]  K. Bro-Jørgensen,et al.  Defects in the Immune System of Mice Infected with Lymphocytic Choriomeningitis Virus , 1974, Infection and immunity.

[280]  W. F. Cleary,et al.  A model in mice for the pathogenesis and treatment of rabies. , 1972, The Journal of infectious diseases.

[281]  Melvin Cohn,et al.  A Theory of Self-Nonself Discrimination , 1970, Science.

[282]  C. Mims,et al.  Pathogenesis of lesions in lymphoid tissue of mice infected with lymphocytic choriomeningitis (LCM) virus. , 1969, British journal of experimental pathology.

[283]  G. Mackaness.  THE INFLUENCE OF IMMUNOLOGICALLY COMMITTED LYMPHOID CELLS ON MACROPHAGE ACTIVITY IN VIVO , 1969, The Journal of experimental medicine.

[284]  C. Mims,et al.  The immunodepressive action of lymphocytic choriomeningitis virus in mice. , 1968, Journal of immunology.

[285]  J. Almeida,et al.  The morphological and biological effects of various antisera on avian infectious bronchitis virus. , 1968, The Journal of general virology.

[286]  K. Johnson,et al.  The pathogenesis of viral infections of the nervous system. , 1968, Neurologic clinics.

[287]  M. Oldstone,et al.  Lymphocytic Choriomeningitis: Production of Antibody by "Tolerant" Infected Mice , 1967, Science.

[288]  C. Wallis,et al.  Virus Aggregation as the Cause of the Non-neutralizable Persistent Fraction , 1967, Journal of virology.

[289]  R. Webster,et al.  DISQUISITIONS ON ORIGINAL ANTIGENIC SIN , 1966, The Journal of experimental medicine.

[290]  R. Webster,et al.  DISQUISITIONS ON ORIGINAL ANTIGENIC SIN : II. PROOF IN LOWER CREATURES , 1966 .

[291]  R. Webster,et al.  Disquisitions of Original Antigenic Sin. I. Evidence in man. , 1966, The Journal of experimental medicine.

[292]  G. Nossal,et al.  Antigens in immunity. VII. Analysis of immunological memory. , 1965, Immunology.

[293]  R. Hawkes,et al.  ENHANCEMENT OF THE INFECTIVITY OF ARBOVIRUSES BY SPECIFIC ANTISERA PRODUCED IN DOMESTIC FOWLS. , 1964, The Australian journal of experimental biology and medical science.

[294]  H. Eisen,et al.  VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE. , 1964, Biochemistry.

[295]  G. Mackaness.  THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE , 1964, The Journal of experimental medicine.

[296]  J. Hotchin,et al.  Protection against the Lethal Effect of Lymphocytic Choriomeningitis Virus in Mice by Neonatal Thymectomy , 1964, Nature.

[297]  K. Lafferty.  THE INTERACTION BETWEEN VIRUS AND ANTIBODY. II. MECHANISM OF THE REACTION. , 1963, Virology.

[298]  K. Lafferty,et al.  The interaction between virus and antibody: III. Examination of virus-antibody complexes with the electron microscope , 1963 .

[299]  G. Mackaness.  CELLULAR RESISTANCE TO INFECTION , 1962, The Journal of experimental medicine.

[300]  R. Webster,et al.  Methods in Immunochemistry of Viruses. 1. Equilibrium Filtration. , 1961 .

[301]  R. Good,et al.  Disturbances in gamma globulin synthesis as experiments of nature. , 1956, Pediatrics.

[302]  R. Dulbecco,et al.  A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus. , 1956, Virology.

[303]  F. Fenner,et al.  Mouse-pox; infectious ectromelia of mice; a review. , 1949, Journal of immunology.

[304]  D. Evans.  PERSISTENCE OF TETANUS ANTITOXIN IN MAN FOLLOWING ACTIVE IMMUNISATION , 1943 .

[305]  제임스 스코트 크라우,et al.  Production of Antibodies , 1942, Nature.

[306]  Behring,et al.  Ueber das Zustandekommen der Diphtherie-Immunität und der Tetanus-Immunität bei Thieren , 1890 .

[307]  D. Nemazee.  Receptor editing in B cells. , 2000, Advances in immunology.

[308]  Gwatkin Dr,et al.  Health inequalities and the health of the poor: What do we know? What can we do? , 2000 .

[309]  N. Cox,et al.  Global epidemiology of influenza: past and present. , 2000, Annual review of medicine.

[310]  D. Gwatkin.  Health inequalities and the health of the poor: what do we know? What can we do? , 2000, Bulletin of the World Health Organization.

[311]  T. Wild,et al.  Measles vaccines, new developments and immunization strategies. , 1999, Vaccine.

[312]  Q. Sattentau,et al.  The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity. , 1999, AIDS.

[313]  J. Roth.  The Immune System , 1999 .

[314]  J. Ravetch,et al.  Divergent roles for Fc receptors and complement in vivo. , 1998, Annual review of immunology.

[315]  R. Zinkernagel,et al.  CD4+ T-cell induction and effector functions: a comparison of immunity against soluble antigens and viral infections. , 1998, Advances in immunology.

[316]  M. Carroll,et al.  The role of complement and complement receptors in induction and regulation of immunity. , 1998, Annual review of immunology.

[317]  E. L. Prak,et al.  Editing disease-associated autoantibodies. , 1997, Immunity.

[318]  R. Zinkernagel,et al.  Neutralizing antiviral B cell responses. , 1997, Annual review of immunology.

[319]  E. Domingo,et al.  RNA virus mutations and fitness for survival. , 1997, Annual review of microbiology.

[320]  R. Zinkernagel,et al.  Specific cytotoxic T cells eliminate cells producing neutralizing antibodies , 1996, Nature.

[321]  R. Zinkernagel,et al.  Mapping of the dominant neutralizing antigenic site of a virus using infected cells. , 1996, Journal of immunological methods.

[322]  M. Barna,et al.  Host immune response to vesicular stomatitis virus infection of the central nervous system in C57BL/6 mice. , 1996, Viral immunology.

[323]  L. Matter,et al.  An outbreak of mumps in a population partially vaccinated with the Rubini strain. , 1996, Scandinavian journal of infectious diseases.

[324]  Barbara J. Culliton,et al.  A year in the life of biomedical research , 1996, Nature Medicine.

[325]  J. Cambier.  New nomenclature for the Reth motif (or ARH1/TAM/ARAM/YXXL) , 1995, Immunology today.

[326]  Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia. World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine. , 1995, The Journal of infectious diseases.

[327]  D. Fearon,et al.  The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. , 1995, Annual review of immunology.

[328]  F. Chisari,et al.  Hepatitis B virus immunopathogenesis. , 1995, Annual review of immunology.

[329]  S. Arya.  Human immunization in developing countries: practical and theoretical problems and prospects. , 1994, Vaccine.

[330]  S. Bondy,et al.  Immunogenicity of synthetic HIV-1 gp120 V3-loop peptide-conjugate immunogens. , 1994, Vaccine.

[331]  I. Frazer,et al.  Immune response to human papillomaviruses and the prospects for human papillomavirus-specific immunisation. , 1994, Current topics in microbiology and immunology.

[332]  P. Matzinger.  Tolerance, danger, and the extended family. , 1994, Annual review of immunology.

[333]  F. Chisari,et al.  Hepatitis B virus persistence after recovery from acute viral hepatitis. , 1994, The Journal of clinical investigation.

[334]  A. Moren,et al.  Measles epidemic in the urban community of Niamey: transmission patterns, vaccine efficacy and immunization strategies, Niger, 1990 to 1991. , 1994, The Pediatric infectious disease journal.

[335]  R. V. van Lier,et al.  Dual antigen recognition by B cells. , 1993, Immunology today.

[336]  M. Buchmeier,et al.  Glycoproteins of the Arenaviruses , 1993 .

[337]  H. Drexhage,et al.  An immunohistochemical study on organized lymphoid cell infiltrates in fetal and neonatal pancreases. A comparison with similar infiltrates found in the pancreas of a diabetic infant. , 1993, Autoimmunity.

[338]  M. Leclerc,et al.  Autoimmunity: from physiology to pathology. Natural antibodies, mucosal immunity and development of B cell repertoire. , 1992, Folia biologica.

[339]  S. Avrameas,et al.  Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. , 1991, Immunology today.

[340]  W. Robinson,et al.  Neutralization and enhancement of in vitro and in vivo HIV and simian immunodeficiency virus infections. , 1990, AIDS.

[341]  I. Wilson,et al.  Structural basis of immune recognition of influenza virus hemagglutinin. , 1990, Annual review of immunology.

[342]  R. Schwartz,et al.  Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. , 1989, Annual review of immunology.

[343]  P. Brandtzaeg.  Overview of the mucosal immune system. , 1989, Current topics in microbiology and immunology.

[344]  M. Oldstone,et al.  Virus-induced immunosuppression: infections with measles virus and human immunodeficiency virus. , 1989, Advances in immunology.

[345]  M. Bendinelli,et al.  Virus-Induced Immunosuppression , 1989, Infectious agents and pathogenesis.

[346]  T. Kurosaki,et al.  A single amino acid in the glycosyl phosphatidylinositol attachment domain determines the membrane topology of Fc gamma RIII. , 1989, Nature.

[347]  R. Zinkernagel,et al.  The role of antibodies in natural and acquired resistance of mice to vesicular stomatitis virus. , 1988, Experimental cell biology.

[348]  A. Nisalak,et al.  A prospective study of dengue infections in Bangkok. , 1988, The American journal of tropical medicine and hygiene.

[349]  R. Wagner.  The Rhabdoviruses , 1987, The Viruses.

[350]  J. S. Porterfield.  Antibody-dependent enhancement of viral infectivity. , 1986, Advances in virus research.

[351]  M. Dietrich,et al.  Spectrum of morphologic changes of lymph nodes from patients with AIDS or AIDS-related complexes. , 1986, Progress in allergy.

[352]  J. Humphrey,et al.  Splenic dependence of the antibody response to thymus‐independent (TI‐2) antigens , 1985, European journal of immunology.

[353]  L. Simar.  [Follicular dendritic cells]. , 1984, Bulletin et memoires de l'Academie royale de medecine de Belgique.

[354]  G. Nossal.  Cellular mechanisms of immunologic tolerance. , 1983, Annual review of immunology.

[355]  R. Schreiber,et al.  Antibody-independent activation of the alternative complement pathway by measles virus-infected cells. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[356]  E. G. Westaway,et al.  A multi-hit model for the neutralization of animal viruses. , 1978, The Journal of general virology.

[357]  F. Murphy.  Rabies pathogenesis. Brief review. , 1977 .

[358]  C. Mims.  The pathogenesis of infectious disease. , 1976 .

[359]  A. Coutinho,et al.  Thymus-independent B-cell induction and paralysis. , 1975, Advances in immunology.

[360]  W. Weigle.  Immunological unresponsiveness. , 1973, Advances in immunology.

[361]  D. Katz,et al.  The regulatory influence of activated T cells on B cell responses to antigen. , 1972, Advances in immunology.

[362]  N. London,et al.  The carrier effect in the secondary response to hapten‐protein conjugates. V. Use of antilymphocyte serum to deplete animals of helper cells , 1971, European journal of immunology.

[363]  M. Raff,et al.  The carrier effect in the secondary response to hapten‐protein conjugates. II. Cellular cooperation , 1971, European journal of immunology.

[364]  J. Hotchin.  The biology of lymphocytic choriomeningitis infection: virus-induced immune disease. , 1962, Cold Spring Harbor symposia on quantitative biology.

[365]  R. W. Brambell.  Problems concerning the transmission of immunity from mother to young. , 1961, Proceedings of the Royal Society of Medicine.

[366]  T. Francis,et al.  A serological recapitulation of human infection with different strains of influenza virus. , 1953, Transactions of the Association of American Physicians.

[367]  N. K. Jerne,et al.  A study of avidity based on rabbit skin responses to diphtheria toxin-antitoxin mixtures. , 1951, Acta pathologica et microbiologica Scandinavica. Supplementum.